We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
Turnover
16.91%
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+0.6%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$4.18M
(-3.5%)
Cap. Flow
-$1.91M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
30.55%
Holding
133
New
11
Increased
32
Reduced
60
Closed
9
Avg Time Held Equity + Options
1.8
years
Top 10 Avg Time Held Equity + Options
0.8
years
Top 20 Avg Time Held Equity + Options
1.4
years
Avg Time Held Equity only
1.8
years
Top 10 Avg Time Held Equity only
0.8
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprott Physical Gold
PHYS
|
+$1.92M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$820K |
| 3 |
BlackRock Core Bond Trust
BHK
|
+$792K |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$767K |
| 5 |
CLNY
Colony Capital, Inc.
CLNY
|
+$546K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$3.5M |
| 2 |
Apple
AAPL
|
+$2.53M |
| 3 |
Alibaba
BABA
|
+$1.63M |
| 4 |
Realty Income
O
|
+$1.24M |
| 5 |
Microsoft
MSFT
|
+$666K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.07% |
| 2 | Real Estate | 17.82% |
| 3 | Healthcare | 11.94% |
| 4 | Technology | 11.86% |
| 5 | Financials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Reading International Class A
RDI
$41M
| $343K | 0.3% |
28,600
-1,500
| -5% | -$16.5K |
2013 Q2
11 quarters
|
|
77
CALL
DELISTED
General Motors Company
GM.WS.B
| $329K | 0.29% |
24,101
-2,000
| -8% | -$25.3K |
2015 Q3
2 quarters
|
|
78
Johnson & Johnson
JNJ
$610B
| $325K | 0.29% |
3,000
| – | – |
2013 Q2
11 quarters
|
|
79
ProShares UltraShort S&P500
SDS
$353M
| $323K | 0.28% |
171
+15
| +10% | +$32.2K |
2015 Q3
2 quarters
|
|
|
MIN
80
Aberdeen Intermediate Income Fund
MIN
$267M
| $322K | 0.28% |
11,650
-500
| -4% | -$13.7K |
2013 Q2
11 quarters
|
|
81
CPI Aerostructures
CVU
$65.9M
| $317K | 0.28% |
43,200
-500
| -1% | -$4.17K |
2013 Q4
9 quarters
|
|
82
Kayne Anderson Energy Infrastructure Fund
KYN
$2.36B
| $309K | 0.27% |
18,650
-500
| -3% | -$7.21K |
2013 Q2
11 quarters
|
|
|
TOO
83
DELISTED
Teekay Offshore Partners L.P.
TOO
| $309K | 0.27% |
54,500
+33,000
| +153% | +$138K |
2015 Q4
1 quarter
|
|
|
XLRN
84
DELISTED
Acceleron Pharma
XLRN
| $303K | 0.27% |
11,500
+5,000
| +77% | +$145K |
2015 Q4
1 quarter
|
|
85
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
| $281K | 0.25% |
2,680
+100
| +4% | +$9.92K |
2013 Q2
11 quarters
|
|
86
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
| $277K | 0.24% |
15,900
| – | – |
2014 Q4
5 quarters
|
|
87
Celldex Therapeutics
CLDX
$2.27B
| $274K | 0.24% |
4,833
+3,490
| +260% | +$393K |
2015 Q4
1 quarter
|
|
88
Verizon
VZ
$184B
| $255K | 0.22% |
4,710
+11
| +0.2% | +$550 |
2014 Q3
6 quarters
|
|
89
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $255K | 0.22% |
+906
| New | +$341K |
2016 Q1
0 quarters
|
|
90
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
| $253K | 0.22% |
8,176
+200
| +3% | +$5.8K |
2014 Q1
8 quarters
|
|
91
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
| $252K | 0.22% |
9,700
| – | – |
2014 Q1
8 quarters
|
|
92
DELISTED
Tsakos Energy Navigation Limited
TNP.PRB.CL
| $252K | 0.22% |
10,300
-100
| -1% | -$2.28K |
2013 Q2
11 quarters
|
|
93
Annaly Capital Management
NLY
$13.9B
| $247K | 0.22% |
6,025
| – | – |
2013 Q2
11 quarters
|
|
94
SPDR Gold Trust
GLD
$142B
| $239K | 0.21% |
2,035
| – | – |
2015 Q3
2 quarters
|
|
95
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $229K | 0.2% |
3,375
| – | – |
2014 Q4
5 quarters
|
|
96
Rockwell Medical
RMTI
$32.2M
| $228K | 0.2% |
276
-19
| -6% | -$14.9K |
2015 Q4
1 quarter
|
|
97
Amgen
AMGN
$235B
| $225K | 0.2% |
1,500
| – | – |
2015 Q4
1 quarter
|
|
98
Macy's
M
$6.33B
| $220K | 0.19% |
+5,000
| New | +$207K |
2016 Q1
0 quarters
|
|
99
Pembina Pipeline
PBA
$28B
| $219K | 0.19% |
+8,100
| New | +$189K |
2016 Q1
0 quarters
|
|
100
Invesco QQQ Trust
QQQ
$487B
| $213K | 0.19% |
1,950
-125
| -6% | -$13K |
2015 Q3
2 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Benchmark Capital Advisors held 133 positions worth $114M, down 3.5% from $118M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q1 2016 filing shows 11 new, 32 increased, 60 reduced and 9 closed positions. Its largest new stake was Teva Pharmaceutical Industries Limited: 13,975 shares worth $748K. The largest sale was GE Aerospace, an estimated $3.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 14% a quarter earlier, followed by Real Estate and Healthcare.
- Benchmark Capital Advisors's largest Q1 2016 buy was Teva Pharmaceutical Industries Limited: 13,975 shares worth $748K.
- Benchmark Capital Advisors added most to Sprott Physical Gold in Q1 2016, an estimated $1.92M increase.
- Benchmark Capital Advisors's biggest Q1 2016 reduction was GE Aerospace, cutting an estimated $3.5M.
- Benchmark Capital Advisors fully exited Alibaba in Q1 2016, selling an estimated $1.63M.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $114M portfolio in Q1 2016.
- Benchmark Capital Advisors opened 11 new positions and closed 9 in Q1 2016.
- Benchmark Capital Advisors's portfolio value fell 3.5% quarter-over-quarter to $114M.
Based on Benchmark Capital Advisors's 13F filing for Q1 2016, filed 10 May 2016.